Roche is reviewing all future investments in Germany over health care cost-cutting policies, with a top executive citing a loss of trust
Back to Lifestyle
Lifestyle
October 19, 2026 at 1:23 PM
STAT+: Pharmalittle: We’re reading about Roche investments in Germany, a Gilead bowel disease drug, and more
STAT News
Excerpt from STAT News.